Leede Financial Analyst Recommendations & Stock PicksView the latest stock recommendations issued by analysts at Leede Financial. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Leede Financial's equity research team. MarketBeat is not affiliated with or endorsed by Leede Financial.Updated 10/29/2025 Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings2 Last 12 MonthsBuy Ratings1 Last 12 MonthsSell Ratings0 Last 12 MonthsCompanies Covered2 Last 12 Months Country All Countries USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Full History Latest Per Company Show All Ratings Strong Buy Buy Hold Sell Rating All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Price Target Change Action Any Change Raised 5%+ Raised 10%+ Raised 20%+ Lowered 5%+ Lowered 10%+ Lowered 20%+ Price Target Change Export CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsEPRXEupraxia Pharmaceuticals$7.27-2.0%10/29/2025 UpgradeStrong-Buy00.00%View details for Leede Financial rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 10/29/2025PMNPromis Neurosciences$11.06-0.1%7/21/2025 UpgradeModerate Buy00.00%View details for Leede Financial rating of Promis Neurosciences (NASDAQ:PMN) on 7/21/2025MDPMedexus PharmaceuticalsC$3.90+0.5%1/22/2025D. LoeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeModerate Buy ➝ Strong-Buy00.00%View details for Leede Financial rating of Medexus Pharmaceuticals (TSE:MDP) on 1/22/2025ONCYOncolytics Biotech$0.92-1.4%11/13/2024D. LoeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Moderate Buy00.00%View details for Leede Financial rating of Oncolytics Biotech (NASDAQ:ONCY) on 11/13/2024DRMedical FacilitiesC$17.1011/7/2024D. LoeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold00.00%View details for Leede Financial rating of Medical Facilities (TSE:DR) on 11/7/2024MDPMedexus PharmaceuticalsC$3.90+0.5%9/30/2024D. LoeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet Price TargetC$8.25Speculative Buy00.00%View details for Leede Financial rating of Medexus Pharmaceuticals (TSE:MDP) on 9/30/2024CPHCipher PharmaceuticalsC$18.11+0.8%9/13/2024D. LoeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold00.00%View details for Leede Financial rating of Cipher Pharmaceuticals (TSE:CPH) on 9/13/2024SVASernovaC$0.18+2.9%9/13/2024 Lower Price TargetC$3.00 ➝ C$1.50Speculative Buy00.00%View details for Leede Financial rating of Sernova (TSE:SVA) on 9/13/2024 MarketBeat Community Rating for Leede FinancialMarketBeat's community ratings are surveys of what our community members think about Leede Financial and other research firms in the last 90 days. Vote "Outperform" if you believe Leede Financial's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leede Financial's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Log in to vote on this brokerage. COMMUNITY RATINGS2.5out of 5 (last 90 days)2.5 of 5 stars OUTPERFORM VOTES 39 Believe will outperform S&P 500 UNDERPERFORM VOTES 39 Believe will underperform S&P 500 Leede Financial Stock Coverage by SectorLeede Financial concentrates its research most heavily in Medical (100.0%). The chart below shows how Leede Financial's 2 rated companies are distributed across all 1 sector it covers.Medical2 companies100.0%Best & Worst CallsBest Call00.0%TSE:MDPSet Price Target • Sep 30, 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TSE:MDPUpgrade • Jan 22, 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI. Leede Financial - Frequently Asked Questions What stocks does Leede Financial currently recommend buying? Leede Financial's analysts currently have buy-equivalent ratings on 1 companies. What sectors does Leede Financial specialize in? Leede Financial has the deepest coverage in Medical (100.0% of rated companies). How often does Leede Financial change its stock ratings? Leede Financial issued 2 ratings over the last 12 months across 2 companies — an average of roughly 0 rating actions per month. These include upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Leede Financial analyst actions. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
